Abbott Laboratories will divide the company into two separate business — one for its medical products and another for research-based medicines, including its pharmaceuticals and biologics, reports
MedCity News.
Both companies will be publicly traded, and the medical products business will retain the Abbott name, with the research-based company still to be named.
Read the full story
here.